Rosa and Co |

Date	Presenter / Topic	Register
Apr 17, 2024 12:00 PM - 01:00 PM EDT	Dr. Michael Monine Scientific Director, Biogen, Cambridge, MA, US Prediction of PK/PD for Intrathecally-Administered Antisense Oligonucleotides	Unlock Webinar
Mar 13, 2024 09:00 AM - 10:00 AM PDT	Amy Moody, PhD Senior Principle Scientist, Pfizer, Cambridge, MA From data driven to theoretical: improving preclinical decision making with modeling	Unlock Webinar
Feb 21, 2024 12:00 PM - 01:00 PM EST	Brian Topp Senior Director, Merck, Rahway NJ The Long Road from Discovery to Design	Unlock Webinar
Jan 17, 2024 12:00 PM - 01:00 PM EST	Tom Yankeelov, Ph.D. W.A. "Tex" Moncrief Chair of Computational Oncology; Director, Center for Computational Oncology, Oden Institute for Computational Engineering and Sciences; Director, Cancer Imaging Research, Livestrong Cancer Institutes; Co-leader, Quantitative Oncology Research Program, Livestrong Cancer Institutes; Adjunct Professor of Imaging Physics, MD Anderson Cancer Center; Professor of Biomedical Engineering, Diagnostic Medicine, Oncology; The University of Texas at Austin, Austin, Texas Clinical Trials For Patients Who Are Not Average	Unlock Webinar
Dec 13, 2023 12:00 PM - 01:00 PM EST	Norman A. Mazer, M.D., Ph.D. Founder and Disease Modeling Consultant, NAM Consulting, Basel, Switzerland The Q-ATN Model of Alzheimer’s Disease: A Work in Progress	Unlock Webinar
Nov 15, 2023 12:00 PM - 01:00 PM EST	Jiawei Zhou, PhD Pharmacometrician, Pfizer Inc., New York, United States Understand Tumor Response Heterogeneity in Colorectal Cancer: Share the similarities, celebrate the differences.	Unlock Webinar
Oct 11, 2023 12:00 PM - 01:00 PM EDT	Mikael Boberg, PhD Senior Scientist, AstraZeneca R&D, Gothenburg, Sweden PK/PD modelling of eflornithine: Assessment of an oral treatment for the fatal parasitic disease human African trypanosomiasis	Unlock Webinar
Aug 16, 2023 12:00 PM - 01:00 PM EDT	Sheena Sharma, PhD Research Investigator, PBPK, Clinical Pharmacology and Pharmacometrics, Bristol Myers Squibb, Lawrenceville, NJ Proteomics-Informed PBPK Modeling to Predict Systemic and Tissue Drug Concentrations in Rats	Unlock Webinar
Sep 13, 2023 12:00 PM - 01:00 PM EDT	Robin T.U. Haid, MSc PhD Student, Bayer AG, Preclinical Development, Drug Metabolism and Pharmacokinetics, Preclinical Modeling and Simulation / ETH Zurich, Institute of Pharmaceutical Sciences, Biopharmacy A Pharmacodynamic Model for the Assessment and Optimization of PROTACs	Unlock Webinar
Jul 12, 2023 12:00 PM - 01:00 PM EDT	Dr. Marcus Rosenblatt, PhD Physicist, Institute of Physics, University of Freiburg, Freiburg, Germany Mechanistic insights into sensitization/desensitization of IFNα signaling and its effect on patient treatment strategies.	Unlock Webinar
Jun 14, 2023 12:00 PM - 01:00 PM EDT	Jared Weddell, Ph.D. Senior Manager, Clinical Pharmacology and Exploratory Development, Astellas Pharma US, Northbrook, IL A QSP model to understand clinical cytokine dynamics following bispecific dosing in solid tumors	Unlock Webinar
May 17, 2023 09:00 AM - 10:00 AM PDT	Robert R. Bies, Pharm.D. Ph.D. FISoP Professor of Pharmaceutical Sciences, Member Institute for Artificial Intelligence and Data Science, University at Buffalo, Buffalo NY Leveraging machine learning strategies for nonlinear mixed effects model selection (using pyDarwin)	Unlock Webinar
Apr 19, 2023 12:00 PM - 01:00 PM EDT	Rebecca Baillie, PhD, Christina Friedrich, PhD, Jake Nichols, PharmD, MBA Principal Scientist; Chief Engineer, Rosa & Co., San Carlos, CA; Director of Medical Affairs, US WorldMeds, Louisville, KY Demonstrating Efficacy When Clinical Trials Are Impossible: QSP Modeling to Support a New Dose Application	Unlock Webinar
Mar 15, 2023 11:00 AM - 12:00 PM PDT	Natalie Morris, BSc University of Bristol, Bristol, UK Defining design rules for next-generation snakebite antivenoms	Unlock Webinar
Jan 18, 2023 09:00 AM - 10:00 AM EST	Vincent Lemaire, Ph.D.; Fei Hua, Ph.D. Distinguished Scientist Modeling and Simulation, Genentech, South San Francisco, CA; VP, Head of Modeling and Simulation Services, Aplied BioMath Concord, MA From Cold to Hot: Perceptions of the Use and Impact of QSP in Immuno-oncology – A Survey of the Community and Stakeholders	Unlock Webinar
Feb 08, 2023 09:00 AM - 10:00 AM PST	Dr Dinko Rekic, PhD and Dr Jane Knöchel, PhD Global Product Leader – ticagrelor; Clinical Pharmacometrician, AstraZeneca, Gothenburg, Sweden A case‐study of model‐informed drug development of a novel PCSK9 antisense oligonucleotide	Unlock Webinar
Dec 12, 2022 12:00 AM - 12:00 AM NULL	The team is taking some time to spend with their families. No Webinar for December	Unlock Webinar
Nov 16, 2022 08:00 AM - 09:00 AM PST	Chuanpu Hu, PhD Senior Scientific Director and Fellow, Janssen R&D, LLC Variability and uncertainty: interpretation and usage of pharmacometric simulations and intervals	Unlock Webinar
Oct 19, 2022 09:00 AM - 10:00 AM PDT	Wojciech Krzyzanski PhD, MA Associate Professor, University at Buffalo Pharmacodynamic age structured population model for cell trafficking	Unlock Webinar
Sep 21, 2022 09:00 AM - 10:00 AM PDT	Philippe Moingeon PhD, MBA Head of Immuno-inflammation portfolio, Servier AI-powered modeling approaches to support the development of new therapies for autoimmune diseases	Unlock Webinar
Aug 17, 2022 09:00 AM - 10:00 AM PDT	Bill Brastow, Ph.D. Chief Technology Officer for Rosa Market Modeling Injecting Reality into Commercial Due Diligence for In-Licensing, Partnering or Purchasing Pharmaceutical Assets in Development	Unlock Webinar
Jul 13, 2022 01:00 PM - 02:00 PM PDT	• Christina Friedrich, PhD, Chief Engineer, Rosa & Co, San Carlos, CA• Stephen Duffull, PhD, Professor, (1) Senior Scientific Advisor, Certara, (2) Otago Pharmacometrics Group, School of Pharmacy, University of Otago, Dunedin, New Zealand• Theodor VPs... You got to know when to hold them, know when to remove them, know when to resample, know when to run.	Unlock Webinar
Jun 15, 2022 09:00 AM - 10:00 AM PDT	Stefano Morotti, PhD. Assistant Professor at University of California Davis Cross-species translation of drug-induced electrophysiological response in cardiac myocytes	Unlock Webinar
May 25, 2022 09:00 AM - 10:00 AM PDT	Chuanpu Hu, PhD. Senior Scientific Director and Fellow at Janssen R&D, LLC Analyzing Outcome Score Data	Unlock Webinar
Apr 20, 2022 09:00 AM - 10:00 AM PDT	Joga Gobburu Professor, University of Maryland Predictive Healthcare Analytics	Unlock Webinar
Mar 16, 2022 09:00 AM - 10:00 AM PDT	Nick Holford, Emeritus Professor Emeritus Professor, University of Auckland, New Zealand Concentration Guided Dosing	Unlock Webinar
Feb 16, 2022 09:00 AM - 10:00 AM PST	Christina Friedrich, PhD; Jérémy Huard Chief Engineer, PhysioPD, Rosa & Co, LLC; Senior Application Engineer, MathWorks Using Machine Learning Surrogate Modeling for Faster QSP VP-Cohort Generation	Unlock Webinar
Jan 20, 2022 09:00 AM - 10:00 AM EST	Check back soon for more webinars. We are taking January off and will resume the webinars in February	Unlock Webinar
Dec 08, 2021 09:00 AM - 10:00 AM PST	Dr. Dipak Barua Research Principal Scientist, Takeda Pharmaceutical Company Limited A mechanistic model-based analysis of Fn14 - NF-Kappa B dysregulation in glioblastoma multiforme	Unlock Webinar
Nov 17, 2021 09:00 AM - 10:00 AM PST	James Lu, PhD Principal AI Scientist, Genentech Using Machine Intelligence in building PK/PD and Disease Progression Models	Unlock Webinar
Oct 20, 2021 09:00 AM - 10:00 AM PDT	Dr Adam Palmer Assistant Professor of Pharmacology, UNC Chapel Hill Models to understand and predict the clinical efficacy of combination cancer therapy	Unlock Webinar
Sep 15, 2021 09:00 AM - 10:00 AM PDT	Yanguang (Carter) Cao, PhD. Assistant Professor \| University of North Carolina at Chapel Hill Probing antibody-target interactions in living systems	Unlock Webinar
Jul 14, 2021 09:00 AM - 10:00 AM PDT	Tongli Zhang, PhD Assistant Professor, University of Cincinnati Integrating Quantitative Systems Pharmacology and Machine learning, why bother?	Unlock Webinar
Jun 09, 2021 12:00 PM - 01:00 PM EDT	Anastasios Siokis, PhD Postdoc in Translational Disease Modeling, Sanofi, Germany An agent-based simulation platform studying the immunological synapse dynamics	Unlock Webinar
May 12, 2021 12:00 PM - 01:00 PM EDT	Vincent Hurez, DVM, PhD Senior Scientist at Rosa & Co LLC Predicting subjective or complex clinical outcomes in QSP models: challenges and approaches	Unlock Webinar
Apr 14, 2021 12:00 PM - 01:00 PM EDT	Thorsten Lehr, PhD Professor of Clinical Pharmacy, Saarland University Cancelled	Unlock Webinar
Mar 17, 2021 12:00 PM - 01:00 PM EDT	Amber Smith, PhD. Assistant Professor at The University of Tennessee Health Science Center The Ravaging Respiratory Infection: Fighting Influenza Using Mechanistic Models	Unlock Webinar
Mar 17, 2021 12:00 PM - 01:00 PM EST	Bill Brastow, PhD Principal and CTO Rosa Market Modeling tbd	Unlock Webinar
Feb 16, 2021 12:00 PM - 01:00 PM EST	Bill Brastow, PhD Principal and CTO Rosa Market Modeling Out of the Lab - Into the Market: Modeling Physician Decision-Making Behavior Using Discrete Choice	Unlock Webinar
Dec 16, 2020 12:00 PM - 01:00 PM EST	Paul B. Watkins, M.D. FAASLD. Director, Institute for Drug Safety Sciences at the University of North Carolina in Chapel Hill QST and the Transformation in Drug Safety Assessment	Unlock Webinar
Jan 20, 2021 12:00 PM - 01:00 PM EST	Luca Gerosa, PhD Postdoctoral Fellow, Laboratory of Systems Pharmacology, at Harvard Medical School Building Kinetic Models with Complex Drug-Protein Interactions: application to the targeted inhibition of MAPK signaling in cancer	Unlock Webinar
Oct 14, 2020 12:00 PM - 01:00 PM EST	Katherine Kudrycki, PhD Principal Scientist at Rosa & Co. LLC Do you need a life scientist for QSP modeling?	Unlock Webinar
Nov 18, 2020 12:00 PM - 01:00 PM EST	Eric Sobie, PhD Professor, Pharmacological Sciences at Icahn School of Medicine at Mount Sinai Using QSP to predict cardiotoxicity caused by cancer drugs	Unlock Webinar
Jul 15, 2020 12:00 PM - 01:00 PM EDT	Dr. Jonathan E. Allen Informatics Thrust Leader, Biosecurity Center at ATOM Consortium and Lawrence Livermore National Laboratory An Integrated Machine Learning Framework for Novel Small Molecule Drug Design	Unlock Webinar
Mar 18, 2020 01:00 PM - 02:00 PM EDT	Dr. Bill Brastow Principal and Chief Technology Officer at Rosa Market Modeling Driving Market Share for Healthcare Products by Integrating Market Modeling	Unlock Webinar
Sep 09, 2020 12:00 PM - 01:00 PM EDT	Stacey Tannenbaum, PhD, FISoP Senior Director, Pharmacometrics US Clinical Pharmacology and Exploratory Development, Astellas Pharma, Northbrook, IL Making the 'Moster' of Your Poster	Unlock Webinar
Apr 15, 2020 12:00 PM - 01:00 PM EDT	Iraj Hosseini, PhD and Justin Feigelman, PhD Scientists at Genentech, Inc in South San Francisco gQSPSim: a SimBiology®-based GUI app for standardized QSP model development and application	Unlock Webinar
May 20, 2020 12:00 PM - 01:00 PM EDT	Paolo Denti, PhD Associate Professor at the University of Cape Town Of “clever” models and “dumb” spreadsheets”: what is more effective to drive policy change?	Unlock Webinar
Jun 17, 2020 12:00 PM - 01:00 PM EDT	Sergio Iadevaia, PhD Scientific Director QSP, Pharmacometrics and Data Analysis at Takeda Development of a QSP Platform to Quantify Benefits of DAAO Inhibition in Schizophrenia	Unlock Webinar
Feb 19, 2020 12:00 PM - 01:00 PM EST	Rajanikanth (Raj) Madabushi, PhD Team Lead, Guidance and Policy & CDER Point-of-Contact for the MIDD paired Meeting Pilot Program, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, USFDA Mainstreaming MIDD: A Holistic and Integrative Approach	Unlock Webinar
Jan 22, 2020 12:00 PM - 01:00 PM EST	Jeffrey R. Sachs, Ph.D. Senior Principal Scientist, Merck & Co., Inc. based in Kenilworth, NJ, USA, known as MSD outside Canada and USA MIDD: Vaccine R&D Gets a Shot in the Arm from Pharmacometrics	Unlock Webinar
Dec 11, 2019 12:00 PM - 01:00 PM EST	Sietse Braakman, PhD SimBiology Application Engineer at MathWorks A general workflow for parameter estimation to help establish confidence in model predictions	Unlock Webinar
Nov 14, 2019 12:00 PM - 01:00 PM EST	Dr. Britta Goebel Head of Translational Disease Modeling (Diabetes-CV & I&I) at Sanofi, Frankfurt Quantitative Systems Pharmacology Modeling Support in Development of Novel Diabetes Treatments	Unlock Webinar
Oct 24, 2019 12:00 PM - 01:00 PM EDT	Robert Bies, Pharm.D. Ph.D Associate Professor of Pharmaceutical Sciences, Member Computational and Data Enabled Sciences Program at the University at Buffalo, NY Hybrid Genetic Algorithm Approaches to Model Selection	Unlock Webinar
Sep 18, 2019 12:00 PM - 01:00 PM EDT	James Yates, MMath, PhD Principal Scientist, AstraZeneca, Cambridge UK Attack of the Clones: Understanding the kinetics of resistance to cancer treatment	Unlock Webinar
Jul 18, 2019 12:00 PM - 01:00 PM EDT	Maria Trujillo PhD Principal Scientist, Merck and Co Inc, Kenilworth, NJ Leveraging a Diabetes QSP Model to Drive Decisions in Target Identification and Validation for Proinsulin to Insulin Conversion Therapy	Unlock Webinar
Jun 20, 2019 12:00 PM - 01:00 PM EDT	Loveleena Bansal, PhD Scientific Leader, GSK Associate Fellow, at GSK, Collegeville PA Modular development and application of platform QSP models to support a broad R&D portfolio: Examples from immuno-oncology and respiratory therapeutic areas	Unlock Webinar
May 23, 2019 12:00 PM - 01:00 PM EDT	Vivaswath S. Ayyar, Ph.D. Adjunct Assistant Professor of Pharmaceutical Sciences, University at Buffalo, NY and PK/PD Scientist, Janssen BioTherapeutics, Spring House, PA Expanding from Basic Towards Systems Pharmacodynamic Models for Methylprednisolone	Unlock Webinar
Apr 17, 2019 12:00 PM - 01:00 PM EDT	Dr.-Ing. Markus Rehberg Scientist QSP at Sanofi-Aventis Deutschland GmbH Systems Immunology Modeling: From Mechanistic Details to Clinical Outcomes in Rheumatoid Arthritis	Unlock Webinar
Mar 14, 2019 12:00 PM - 01:00 PM EDT	Stephan Schmidt, B.Pharm, Ph.D., F.C.P. Associate Professor & Associate Director, Center for Pharmacometrics & Systems Pharmacology, University of Florida Pharmacometrics, PBPK, QSP – What’s Next?	Unlock Webinar
Feb 12, 2019 12:00 PM - 01:00 PM EST	Professor Ioannis (Yannis) P. Androulakis Rutgers University - Biomedical Engineering Dynamic Models for Personalized QSP: How models can help us explore big data	Unlock Webinar
Jan 23, 2019 12:00 PM - 01:00 PM EST	Chi-Chung Li, Ph.D., Senior Scientist, Clinical Pharmacology, and Iraj Hosseini, PhD. Scientist Genentech, Roche, South San Francisco. Enhancing Phase I Clinical Decision Making Through the Use of Quantitative Systems Pharmacology Modeling: A Case Study of Mosunetuzumab in Relapsed/Refractory Non-Hodgkin’s Lymphoma	Unlock Webinar
Dec 12, 2018 12:00 PM - 01:00 PM EST	Eric Sobie, PhD, Professor, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY Combining mechanistic modeling with machine learning to predict cardiotoxicity and streamline drug development	Unlock Webinar
Nov 14, 2018 12:00 PM - 01:00 PM EST	Theresa Yuraszeck, Associate Director, Quantitative Pharmacology, CSL Behring Quantitative Approaches to Informing Clinical Decisions – Where does Systems Pharmacology Fit In?	Unlock Webinar
Jul 18, 2018 01:00 PM - 02:00 PM EDT	Richard Gliklich, MD, Founder and CEO, OM1 Advancing Drug Development and Outcomes Research with Artificial Intelligence, Machine Learning, and Predictive Models	Unlock Webinar
Oct 24, 2018 01:00 PM - 02:00 PM EDT	Iraj Hosseini, PhD. Scientist at Genentech The gPKPDsim Simbiology app	Unlock Webinar
Sep 20, 2018 12:00 PM - 01:00 PM EDT	Prasad Dhurjati, PhD, Professor of Chemical & Bio-molecular Engineering, Joint appointment as Professor Biological Sciences and Professor of Mathematical Sciences, University of Delaware System Level Modeling of the Human Gut Microbiome	Unlock Webinar
May 17, 2018 01:00 PM - 02:00 PM EDT	1) Lealem Mulugeta, Executive Committee Member of CPMS, Founder/Executive of InSilico Labs and Medalist Fitness.2) Andrew Drach, Senior Research Fellow at University of Texas at Austin, Executive Committee Member of CPMS Ten Simple Rules of Credible Practice of Modeling and Simulation in Healthcare: Application to Bone Remodeling and Heart Valve Modeling	Unlock Webinar
Jun 13, 2018 12:00 PM - 01:00 PM EDT	Aman Singh, PK-PD Scientist, Biologics Development Sciences, Janssen R&D Towards Development of a Systems PK-PD Model to Characterize Bystander Effect of Antibody-Drug Conjugates (ADCs)	Unlock Webinar
Apr 25, 2018 12:00 PM - 01:00 PM EST	Christina Friedrich, PhD, Chief Engineer, and Mike Reed, PhD, Chief Scientist, Rosa & Co, CA How to Ensure Your QSP Model is Useful – Illustrative Examples and Lessons Learned	Unlock Webinar
Mar 14, 2018 12:00 PM - 01:00 PM EST	Richard A. Gray, PhD, Senior Research Biomedical Engineer, Food and Drug Administration, Silver Spring, MD The Potential Impact of Physiological Computer Models in Medicine: Regulation and Considerations for Ensuring Patient Safety	Unlock Webinar
Jan 25, 2018 04:00 PM - 05:00 PM EST	Chihiro Hasegawa, PhD, PK/PD Scientist, Ono Pharma, Japan, Otago Pharmacometrics Group, School of Pharmacy, University of Otago, New Zealand Automated scale reduction of nonlinear QSP models with an example of a bone biology system	Unlock Webinar
Feb 14, 2018 12:00 PM - 01:00 AM EST	Frank Gibbons, PhDPrincipal Scientist, DMPK, IMED Oncology Biotech UnitAstraZeneca Pulling your model up by its bootstraps: evolving your way to QSP	Unlock Webinar
Oct 26, 2017 12:00 PM - 01:00 PM EDT	Sietse Braakman, PhDMathWorks Enabling QSP and PK/PD workflows using SimBiology and MATLAB: What’s New?	Unlock Webinar
Sep 13, 2017 11:00 AM - 12:00 PM EDT	Dr. Ryan TasseffScientistProcter and Gamble Development of a multiscale skin barrier model for de novo, in silico prediction	Unlock Webinar
Dec 13, 2017 12:00 PM - 01:00 AM EST	Konstantinos (Kostas) Biliouris, PhD Principal Pharmacometrics Scientist Novartis Cambridge, MA, USA Quantitative Modeling in Support of the Development of a Systemic Lupus Erythematosus Drug	Unlock Webinar
Nov 16, 2017 12:00 PM - 01:00 PM EST	Nelleke Snelder Senior Consultant LAP&P Consultants BV Leiden, The Netherlands QSP modelling - at the heart of the action.	Unlock Webinar
Apr 18, 2011 04:00 PM - 04:00 PM EST	Joga Gobburu, PhD, Division of Parmacometrics, OCP/FDA Learn & Apply Paradigm in Drug Development: How disease-drug-trial models can aid decisions	Unlock Webinar
Jul 20, 2012 12:00 AM - 12:00 AM PDT	Dr. Valeriu Damian-Iordache, Director Pharmacokinetics and Translational Biology, GlaxoSmithKline Physiological based modeling for ocular drug delivery	Unlock Webinar
Jun 19, 2012 12:00 AM - 12:00 AM PDT	Dr. Scott Q Siler, Lead DILI-sim Consultant The DILIsym™ model and its application to hepatotoxicity testing in drug development	Unlock Webinar
May 22, 2012 12:00 AM - 12:00 AM PDT	Dr. Toufigh Gordi, Rosa and Co.; President, PK/PD and Clinical Pharmacology Services Mechanistic PK/PD Modeling in Pediatrics	Unlock Webinar
Apr 17, 2012 12:00 AM - 12:00 AM PDT	Dr. Birgit Schoeberl; Vice President of Discovery; Merrimack Pharmaceuticals Using mathematical models to set design criteria for antibody-based therapies	Unlock Webinar
Mar 20, 2012 12:00 AM - 12:00 AM PDT	Joga Gobburu, PhD FCP MBA; School of Pharmacy\|School of Medicine, Univ. of Maryland, Baltimore Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions	Unlock Webinar
Feb 13, 2012 12:00 AM - 12:00 AM PDT	Hartmut Derendorf, PhD; University of Florida, Gainesville PK/PD-based Development of Anti-infective Agents	Unlock Webinar
Dec 13, 2011 12:00 AM - 12:00 AM PDT	Tristan Maurer, PharmD, PhD; Research Fellow at Pfizer Pharmaceuticals Translational Modeling & Simulation in Support of Rational Drug Discovery: Principles, Challenges and Examples	Unlock Webinar
Nov 14, 2011 12:00 AM - 12:00 AM PDT	William J. Jusko, PhD, SUNY (Buffalo) Moving PK/PD From Basic Towards Systems Pharmacology	Unlock Webinar
Oct 17, 2011 12:00 AM - 12:00 AM PDT	Christina Friedrich, PhD, Rosa & Co Developing Models that are Fit for Purpose — A Model Qualification Method	Unlock Webinar
Sep 19, 2011 12:00 AM - 12:00 AM PDT	Nick Holford, MBChB, University of Auckland, New Zealand Clinical Pharmacology = Disease Progression + Drug Action	Unlock Webinar
Jul 26, 2011 12:00 AM - 12:00 AM PDT	Herbert Sauro, PhD, University of Washington, Seattle Standards and Software in Biomedical Systems Modeling	Unlock Webinar
Jun 20, 2011 12:00 AM - 12:00 AM PDT	Rebecca Baillie, PhD, Rosa & Co How to build a PhysioPD model	Unlock Webinar
May 24, 2011 12:00 AM - 12:00 AM PDT	Rada Savic, PhD, Uppsala University Overview of modeling tools in drug development	Unlock Webinar
Oct 16, 2013 12:00 AM - 12:00 AM PDT	Dr. Frank Bergmann, University of Heidelberg Applying the Scientific Method to Simulation Experiments	Unlock Webinar
Sep 24, 2013 12:00 AM - 12:00 AM PDT	Tarek Leil, Director, Bristol-Myers Squibb A Bayesian Perspective on Estimation of Variability and Uncertainty in Mechanism-Based Models	Unlock Webinar
Jul 18, 2013 12:00 AM - 12:00 AM PDT	Robert Leipold, Research Scientist, Evidera Modeling in Healthcare Economic Evaluations	Unlock Webinar
Jun 19, 2013 12:00 AM - 12:00 AM PDT	Dean Bottino, Head Modeling & Simulation Oncology at Roche Pharmaceuticals Multi-scale modeling to optimize the antitumor effect of antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced therapies	Unlock Webinar
May 15, 2013 12:00 AM - 12:00 AM PDT	Michael A. Eldon, Principal Scientific Fellow, VP, Clinical Pharmacology, Nektar Therapeutics PK/PD Modeling and simulation: Applications in discovery through development	Unlock Webinar
Apr 24, 2013 12:00 AM - 12:00 AM PDT	Christina Friedrich, Chief Engineer, Rosa and Co. Learnings from the Field: The Rosa Physiological Model Qualification Method	Unlock Webinar
Mar 13, 2013 12:00 AM - 12:00 AM PDT	David J. Klinke II, Ph.D, Associate Professor, Chemical Engineering; West Virginia University In silico model-based inference: A contemporary approach for hypothesis testing in systems	Unlock Webinar
Feb 19, 2013 12:00 AM - 12:00 AM PDT	Dr. Chee Ng, Assistant Professor at Children's Hospital of Philadelphia Model-based Discovery/Development of Therapeutic Monoclonal Antibodies	Unlock Webinar
Dec 11, 2012 12:00 AM - 12:00 AM PDT	Dhavalkumar Shah, Senior Scientist; Modeling & Simulation, Pharmacokinetics, Dynamics, and Metabolism; Pfizer Bench to Bedside Translation of Antibody Drug Conjugates Using a Multiscale Mechanistic PK/PD Model: A Case Study with SGN-35	Unlock Webinar
Nov 14, 2012 12:00 AM - 12:00 AM PDT	Arthur Lo, Senior Scientist; Theravance Integration of in vitro data into a viral kinetics model to investigate rapid development of Hepatitis C resistance to therapy	Unlock Webinar
Oct 17, 2012 12:00 AM - 12:00 AM PDT	Pratap Singh, Ph.D, Senior Principal Scientist, Pfizer Role of Myostatin in Muscle Growth: Key Learnings From PK/PD Modeling Analysis	Unlock Webinar
Sep 19, 2012 04:00 PM - 04:00 PM EST	Malcolm Rowland, PhD, Professor Emeritus, University of Manchester Addressing drug development questions with physiologically based pharmacokinetics	Unlock Webinar
Jan 14, 2015 12:00 AM - 12:00 AM PDT	Dr. Richard Peck, Global Head Clinical Pharmacology, Pharmaceutical Research and Development (pRED), Roche Products Ltd How can We Use Mechanism-based Receptor Models for Designing First in Human Studies?	Unlock Webinar
Dec 17, 2014 12:00 AM - 12:00 AM PDT	Mike Reed, Chief Scientist, PhysioPD, Rosa & Co Building and Using a Quantitative Systems Pharmacology Model: Overview and Case Study	Unlock Webinar
Oct 22, 2014 12:00 AM - 12:00 AM PDT	Hugo Geerts Scientific Liaison Officer at In Silico Biosciences Quantitative Systems Pharmacology in CNS Disorders Providing value for Pharmaceutical R&D in Neurology and Psychiatry	Unlock Webinar
Sep 24, 2014 12:00 AM - 12:00 AM PDT	Dhaval Shah Assistant Professor at SUNY Buffalo Evolution of the Platform PBPK Model for Monoclonal Antibodies Towards Pediatric Population	Unlock Webinar
Jul 16, 2014 12:00 AM - 12:00 AM PDT	Marc Birtwistle, PhD; Asst Professor, Pharmacology and Systems Therapeutics, Icahn School of Medicine, Mount Sinai, NY Noise and Signaling in Cancer Systems Pharmacology	Unlock Webinar
Jun 13, 2014 12:00 AM - 12:00 AM PDT	Yu-Nien (Tom) Sun, Director, Quantitative Pharmacology Group; Pharmacokinetics & Drug Metabolism Department, Amgen, Inc. Model-Based Drug Development for Oncology Therapeutics	Unlock Webinar
May 14, 2014 12:00 AM - 12:00 AM PDT	Kapil Gadkar, Scientist at Genentech A mechanistic systems pharmacology model for prediction of LDL cholesterol lowering by anti-PCSK9 in human dyslipidemia	Unlock Webinar
Apr 17, 2014 04:00 PM - 04:00 PM EST	C.J. Musante, Associate Research Fellow, Cardiovascular and Metabolic Diseases; Gianluca Nucci, Senior Director, Clinical Pharmacology, and Mark Peterson Director, Pharmacometrics, Pfizer Inc. Quantitative Systems Pharmacology at Pfizer: A Paradigm Shift to Improve the Probability of Successful Proof of Concept Studies	Unlock Webinar
Mar 19, 2014 12:00 AM - 12:00 AM PDT	Thierry Lave, Head DMPK and TOX Project Leader and Modeling and Simulation, F. Hoffmann-La Roche Translational modeling in support of nonclinical safety assessments	Unlock Webinar
Feb 27, 2014 12:00 AM - 12:00 AM PDT	Ron Beaver, PhD, Founder, Chairman, and CEO, Rosa & Co LLC Systems Pharmacology: Science or Non-science? And so what?	Unlock Webinar
Dec 11, 2013 12:00 AM - 12:00 AM PDT	Dr. Yanguang Cao, Research Assistant Professor, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY Applications of minimal PBPK models to small and large molecules	Unlock Webinar
Nov 13, 2013 12:00 AM - 12:00 AM PDT	Kosmas Kretsos, Associate Director, Global Exploratory Development, UCB New Medicines Differentiate or die: Preclinical and early clinical assessment of differentiation potential via modeling	Unlock Webinar
Dec 09, 2015 12:00 AM - 12:00 AM PDT	Stephen Duffull, PhD, Chair of Clinical Pharmacy, Otago Pharmacometrics Group, School of Pharmacy, University of Otago, Dunedin, New Zealand Systems models–their use and simplification	Unlock Webinar
Oct 14, 2015 12:00 AM - 12:00 AM PDT	Ananth Kadambi, Ph.D., Senior Vice President, PhysioPD™, Rosa & Co. Differential applications of Quantitative Systems Pharmacology and traditional modeling approaches in pharmaceutical R&D	Unlock Webinar
Sep 16, 2015 12:00 AM - 12:00 AM PDT	Satyaprakash Nayak (Satya), Pharmacometrician - Systems Biologist at Pfizer Development of a Quantitative Systems Pharmacology Model of the Blood Coagulation Network & its Application to Clinical Programs	Unlock Webinar
Jul 17, 2015 12:00 AM - 12:00 AM PDT	Peter L. Bonate, PhD, Senior Director, Astellas; Global Head - Pharmacokinetics, Modeling, and Simulation; Global Clinical Pharmacology & Exploratory Development Modeler Tailor Listener Buy	Unlock Webinar
Jun 17, 2015 12:00 AM - 12:00 AM PDT	Eric A. Sobie Ph.D., Associate Professor, Dept. of Pharmacology and Systems Therapeutics; Icahn School of Medicine at Mount Sinai, NYC, NY Quantitative Cardiovascular Systems Pharmacology: Exploiting mathematical models to generate novel insight	Unlock Webinar
May 13, 2015 12:00 AM - 12:00 AM PDT	Loveleena Bansal, PhD, Post-Doctoral Researcher, GlaxoSmithKline A Quantitative Systems Pharmacology (QSP) Approach to Understand the Pathogenesis of Acne and Evaluate New Acne Therapies	Unlock Webinar
Apr 16, 2015 04:00 PM - 04:00 PM EST	Dr. Ioannis (Yannis) P. Androulakis, Professor, Rutgers University, Piscataway, NJ Systems engineering meets Quantitative Systems Pharmacology: From low-level targets to engaging the host defenses	Unlock Webinar
Mar 11, 2015 12:00 AM - 12:00 AM PDT	Samik Ghosh, PhD, The Systems Biology Institute, Tokyo, Japan Garuda: Fly to the future of biology	Unlock Webinar
Feb 11, 2015 12:00 AM - 12:00 AM PDT	Sandra Visser, Principal Scientist, Early Stage Quantitative Pharmacology & Pharmacometrics, Merck Bringing Quantitative and Systems Pharmacology to Drug Discovery: Implementation, Impact, and Challenges	Unlock Webinar
Oct 19, 2016 04:00 PM - 04:00 PM EST	Michael Bolger, Ph.D., Chief Scientist and Ted Grasela, Ph.D., President, Simulations Plus; Lancaster, CA Applying QSAR and PBPK Modeling to Bridge Discovery and Assessment of Clinical Potential	Unlock Webinar
Sep 14, 2016 12:00 AM - 12:00 AM PDT	Helen Moore, PhD, Associate Director, Quantitative Clinical Pharmacology, Bristol-Myers Squibb, Princeton, NJ Mathematical Optimization of Combination Therapy Regimens	Unlock Webinar
Jul 13, 2016 04:00 PM - 04:00 PM EST	Christina Friedrich, PhD, Chief Engineer, Rosa & Co., San Carlos, CA and Fulden Buyukozturk, PhD, Technical Evangelist, MathWorks; Natick, MA MATLAB and SimBiology facilitate QSP modeling and analysis to support drug development	Unlock Webinar
Jun 15, 2016 12:00 AM - 12:00 AM PDT	Melissa Hallow, Ph.D., Assistant Professor, College Of Engineering And Department Of Epidemiology And Biostatistics, University of Georgia, Athens, GA Application of Physiology - Disease-Drug Model of Kidney Disease	Unlock Webinar
May 11, 2016 12:00 AM - 12:00 AM PDT	Jonathan Wagg, MD, PhD, Disease Therapeutic Area Modeling Leader – Oncology, Roche Pharmaceutical Research and Early Development Optimizing Delivery of Cancer Vaccines: Short Peptides Insights from Disease Modelling	Unlock Webinar
Apr 13, 2016 04:00 PM - 04:00 PM EST	Oliver Ghobrial, Sr. Scientist III, Systems Pharmacology/DMPK/PKPD, AbbVie, Inc. AbbVie Dermatology QSP Platform: Build Strategy and Applications in Psoriasis Drug Discovery and Clinical Development	Unlock Webinar
Mar 16, 2016 04:00 PM - 04:00 PM EST	Dr. Lourdes Cucurull-Sanchez, Senior Scientific Investigator; GlaxoSmithKline Modelling Cytokine Receptors as Drug Targets – A Case Study	Unlock Webinar
Jul 19, 2017 12:00 PM - 01:00 PM EDT	Valeriu Damian, DirectorSystems Modeling and Translational Biology GlaxoSmithKline, King of Prussia, PA QSP - What’s in it for me? Case study examples	Unlock Webinar
Jun 14, 2017 12:00 PM - 01:00 PM EDT	Dr. Herbert Sauro, Associate Professor, Bioengineering, University of Washington Approaches to Reproducibility in Systems and Physiological Modeling	Unlock Webinar
Apr 19, 2017 12:00 PM - 01:00 PM EDT	Aman P. Singh, PhD CandidateDepartment of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY A PK-PD Modeling and Simulation Based Strategy for Clinical Translation of Antibody-Drug Conjugates: A case study with T-DM1	Unlock Webinar
Mar 22, 2017 12:00 PM - 01:00 PM EDT	Dr. Michael Weis, Senior Engineer, PhysioPD™, Rosa & Co. Considerations for adopting models for PhysioPD-style Research	Unlock Webinar
Feb 24, 2017 12:00 PM - 01:00 PM EST	Stacey Tannenbaum, PhD, FISoP Director: Pharmacokinetics, Modeling, and Simulation Clinical Pharmacology & Exploratory Development Astellas Pharma Global Development; Northbrook, IL Pharmacometricians and Statisticians in Drug Development: Can’t We All Just Get Along?	Unlock Webinar
Jan 18, 2017 12:00 PM - 01:00 PM EST	Natal van Riel, MSc, PhD Professor Computational Modelling Associate Professor Systems Biology and Metabolic Disease Eindhoven University of Technology, and Amsterdam Medical Center Eindhoven, The Netherlands Quantification of Variability and Uncertainty in Multi-Level Systems Pharmacology Models	Unlock Webinar
Dec 14, 2016 12:00 PM - 01:00 PM EST	Ben-Fillippo Krippendorff, Ph.D.Quantitative Systems Pharmacology, Pharmaceutical SciencesRoche Pharma Research & Early DevelopmentRoche Innovation Center Basel Predicting Tissue Distribution and Clearance of Large Molecules to Improve Selectivity of Targeted Therapies	Unlock Webinar
Nov 16, 2016 11:00 AM - 12:00 PM EST	Craig Thalhauser, Ph.D., Associate Director/Quantitative Clinical Pharmacology, Bristol-Myers Squibb, Princeton, NJ Calibration, Validation, and Responder Analysis in a Virtual Population of Rheumatoid Arthritis Patients	Unlock Webinar

Dr. Michael Monine Scientific Director, Biogen, Cambridge, MA, US

Prediction of PK/PD for Intrathecally-Administered Antisense Oligonucleotides

Amy Moody, PhD Senior Principle Scientist, Pfizer, Cambridge, MA

From data driven to theoretical: improving preclinical decision making with modeling

Brian Topp Senior Director, Merck, Rahway NJ

The Long Road from Discovery to Design

Clinical Trials For Patients Who Are Not Average

Norman A. Mazer, M.D., Ph.D. Founder and Disease Modeling Consultant, NAM Consulting, Basel, Switzerland

The Q-ATN Model of Alzheimer’s Disease: A Work in Progress

Jiawei Zhou, PhD Pharmacometrician, Pfizer Inc., New York, United States

Understand Tumor Response Heterogeneity in Colorectal Cancer: Share the similarities, celebrate the differences.

Mikael Boberg, PhD Senior Scientist, AstraZeneca R&D, Gothenburg, Sweden

PK/PD modelling of eflornithine: Assessment of an oral treatment for the fatal parasitic disease human African trypanosomiasis

Sheena Sharma, PhD Research Investigator, PBPK, Clinical Pharmacology and Pharmacometrics, Bristol Myers Squibb, Lawrenceville, NJ

Proteomics-Informed PBPK Modeling to Predict Systemic and Tissue Drug Concentrations in Rats

Robin T.U. Haid, MSc PhD Student, Bayer AG, Preclinical Development, Drug Metabolism and Pharmacokinetics, Preclinical Modeling and Simulation / ETH Zurich, Institute of Pharmaceutical Sciences, Biopharmacy

A Pharmacodynamic Model for the Assessment and Optimization of PROTACs

Dr. Marcus Rosenblatt, PhD Physicist, Institute of Physics, University of Freiburg, Freiburg, Germany

Mechanistic insights into sensitization/desensitization of IFNα signaling and its effect on patient treatment strategies.

Jared Weddell, Ph.D. Senior Manager, Clinical Pharmacology and Exploratory Development, Astellas Pharma US, Northbrook, IL

A QSP model to understand clinical cytokine dynamics following bispecific dosing in solid tumors

Robert R. Bies, Pharm.D. Ph.D. FISoP Professor of Pharmaceutical Sciences, Member Institute for Artificial Intelligence and Data Science, University at Buffalo, Buffalo NY

Leveraging machine learning strategies for nonlinear mixed effects model selection (using pyDarwin)

Rebecca Baillie, PhD, Christina Friedrich, PhD, Jake Nichols, PharmD, MBA Principal Scientist; Chief Engineer, Rosa & Co., San Carlos, CA; Director of Medical Affairs, US WorldMeds, Louisville, KY

Demonstrating Efficacy When Clinical Trials Are Impossible: QSP Modeling to Support a New Dose Application

Natalie Morris, BSc University of Bristol, Bristol, UK

Defining design rules for next-generation snakebite antivenoms

Vincent Lemaire, Ph.D.; Fei Hua, Ph.D. Distinguished Scientist Modeling and Simulation, Genentech, South San Francisco, CA; VP, Head of Modeling and Simulation Services, Aplied BioMath Concord, MA

From Cold to Hot: Perceptions of the Use and Impact of QSP in Immuno-oncology – A Survey of the Community and Stakeholders

Dr Dinko Rekic, PhD and Dr Jane Knöchel, PhD Global Product Leader – ticagrelor; Clinical Pharmacometrician, AstraZeneca, Gothenburg, Sweden

A case‐study of model‐informed drug development of a novel PCSK9 antisense oligonucleotide

The team is taking some time to spend with their families.

No Webinar for December

Chuanpu Hu, PhD Senior Scientific Director and Fellow, Janssen R&D, LLC

Variability and uncertainty: interpretation and usage of pharmacometric simulations and intervals

Wojciech Krzyzanski PhD, MA Associate Professor, University at Buffalo

Pharmacodynamic age structured population model for cell trafficking

Philippe Moingeon PhD, MBA Head of Immuno-inflammation portfolio, Servier

AI-powered modeling approaches to support the development of new therapies for autoimmune diseases

Bill Brastow, Ph.D. Chief Technology Officer for Rosa Market Modeling

Injecting Reality into Commercial Due Diligence for In-Licensing, Partnering or Purchasing Pharmaceutical Assets in Development

• Christina Friedrich, PhD, Chief Engineer, Rosa & Co, San Carlos, CA• Stephen Duffull, PhD, Professor, (1) Senior Scientific Advisor, Certara, (2) Otago Pharmacometrics Group, School of Pharmacy, University of Otago, Dunedin, New Zealand• Theodor

VPs... You got to know when to hold them, know when to remove them, know when to resample, know when to run.

Stefano Morotti, PhD. Assistant Professor at University of California Davis

Cross-species translation of drug-induced electrophysiological response in cardiac myocytes

Chuanpu Hu, PhD. Senior Scientific Director and Fellow at Janssen R&D, LLC

Analyzing Outcome Score Data

Joga Gobburu Professor, University of Maryland

Predictive Healthcare Analytics

Nick Holford, Emeritus Professor Emeritus Professor, University of Auckland, New Zealand

Concentration Guided Dosing

Christina Friedrich, PhD; Jérémy Huard Chief Engineer, PhysioPD, Rosa & Co, LLC; Senior Application Engineer, MathWorks

Using Machine Learning Surrogate Modeling for Faster QSP VP-Cohort Generation

Check back soon for more webinars.

We are taking January off and will resume the webinars in February

Dr. Dipak Barua Research Principal Scientist, Takeda Pharmaceutical Company Limited

A mechanistic model-based analysis of Fn14 - NF-Kappa B dysregulation in glioblastoma multiforme

James Lu, PhD Principal AI Scientist, Genentech

Using Machine Intelligence in building PK/PD and Disease Progression Models

Dr Adam Palmer Assistant Professor of Pharmacology, UNC Chapel Hill

Models to understand and predict the clinical efficacy of combination cancer therapy

Yanguang (Carter) Cao, PhD. Assistant Professor | University of North Carolina at Chapel Hill

Probing antibody-target interactions in living systems

Tongli Zhang, PhD Assistant Professor, University of Cincinnati

Integrating Quantitative Systems Pharmacology and Machine learning, why bother?

Anastasios Siokis, PhD Postdoc in Translational Disease Modeling, Sanofi, Germany

An agent-based simulation platform studying the immunological synapse dynamics

Vincent Hurez, DVM, PhD Senior Scientist at Rosa & Co LLC

Predicting subjective or complex clinical outcomes in QSP models: challenges and approaches

Thorsten Lehr, PhD Professor of Clinical Pharmacy, Saarland University

Cancelled

Amber Smith, PhD. Assistant Professor at The University of Tennessee Health Science Center

The Ravaging Respiratory Infection: Fighting Influenza Using Mechanistic Models

Bill Brastow, PhD Principal and CTO Rosa Market Modeling

tbd

Bill Brastow, PhD Principal and CTO Rosa Market Modeling

Out of the Lab - Into the Market: Modeling Physician Decision-Making Behavior Using Discrete Choice

Paul B. Watkins, M.D. FAASLD. Director, Institute for Drug Safety Sciences at the University of North Carolina in Chapel Hill

QST and the Transformation in Drug Safety Assessment

Luca Gerosa, PhD Postdoctoral Fellow, Laboratory of Systems Pharmacology, at Harvard Medical School

Dr. Michael Monine
Scientific Director, Biogen, Cambridge, MA, US

Amy Moody, PhD
Senior Principle Scientist, Pfizer, Cambridge, MA

Brian Topp
Senior Director, Merck, Rahway NJ

Norman A. Mazer, M.D., Ph.D.
Founder and Disease Modeling Consultant, NAM Consulting, Basel, Switzerland

Jiawei Zhou, PhD
Pharmacometrician, Pfizer Inc., New York, United States

Mikael Boberg, PhD
Senior Scientist, AstraZeneca R&D, Gothenburg, Sweden

Sheena Sharma, PhD
Research Investigator, PBPK, Clinical Pharmacology and Pharmacometrics, Bristol Myers Squibb, Lawrenceville, NJ

Robin T.U. Haid, MSc
PhD Student, Bayer AG, Preclinical Development, Drug Metabolism and Pharmacokinetics, Preclinical Modeling and Simulation / ETH Zurich, Institute of Pharmaceutical Sciences, Biopharmacy

Dr. Marcus Rosenblatt, PhD
Physicist, Institute of Physics, University of Freiburg, Freiburg, Germany

Jared Weddell, Ph.D.
Senior Manager, Clinical Pharmacology and Exploratory Development, Astellas Pharma US, Northbrook, IL

Robert R. Bies, Pharm.D. Ph.D. FISoP
Professor of Pharmaceutical Sciences, Member Institute for Artificial Intelligence and Data Science, University at Buffalo, Buffalo NY

Rebecca Baillie, PhD, Christina Friedrich, PhD, Jake Nichols, PharmD, MBA
Principal Scientist; Chief Engineer, Rosa & Co., San Carlos, CA; Director of Medical Affairs, US WorldMeds, Louisville, KY

Natalie Morris, BSc
University of Bristol, Bristol, UK

Vincent Lemaire, Ph.D.; Fei Hua, Ph.D.
Distinguished Scientist Modeling and Simulation, Genentech, South San Francisco, CA; VP, Head of Modeling and Simulation Services, Aplied BioMath Concord, MA

Dr Dinko Rekic, PhD and Dr Jane Knöchel, PhD
Global Product Leader – ticagrelor; Clinical Pharmacometrician, AstraZeneca, Gothenburg, Sweden

Chuanpu Hu, PhD
Senior Scientific Director and Fellow, Janssen R&D, LLC

Wojciech Krzyzanski PhD, MA
Associate Professor, University at Buffalo

Philippe Moingeon PhD, MBA
Head of Immuno-inflammation portfolio, Servier

Bill Brastow, Ph.D.
Chief Technology Officer for Rosa Market Modeling

Stefano Morotti, PhD.
Assistant Professor at University of California Davis

Chuanpu Hu, PhD.
Senior Scientific Director and Fellow at Janssen R&D, LLC

Joga Gobburu
Professor, University of Maryland

Nick Holford, Emeritus Professor
Emeritus Professor, University of Auckland, New Zealand

Christina Friedrich, PhD; Jérémy Huard
Chief Engineer, PhysioPD, Rosa & Co, LLC; Senior Application Engineer, MathWorks

Dr. Dipak Barua
Research Principal Scientist, Takeda Pharmaceutical Company Limited

James Lu, PhD
Principal AI Scientist, Genentech

Dr Adam Palmer
Assistant Professor of Pharmacology, UNC Chapel Hill

Yanguang (Carter) Cao, PhD.
Assistant Professor | University of North Carolina at Chapel Hill

Tongli Zhang, PhD
Assistant Professor, University of Cincinnati

Anastasios Siokis, PhD
Postdoc in Translational Disease Modeling, Sanofi, Germany

Vincent Hurez, DVM, PhD
Senior Scientist at Rosa & Co LLC

Thorsten Lehr, PhD
Professor of Clinical Pharmacy, Saarland University

Amber Smith, PhD.
Assistant Professor at The University of Tennessee Health Science Center

Bill Brastow, PhD
Principal and CTO Rosa Market Modeling

Bill Brastow, PhD
Principal and CTO Rosa Market Modeling

Paul B. Watkins, M.D. FAASLD.
Director, Institute for Drug Safety Sciences at the University of North Carolina in Chapel Hill

Luca Gerosa, PhD
Postdoctoral Fellow, Laboratory of Systems Pharmacology, at Harvard Medical School

Katherine Kudrycki, PhD
Principal Scientist at Rosa & Co. LLC

Eric Sobie, PhD
Professor, Pharmacological Sciences at Icahn School of Medicine at Mount Sinai

Dr. Jonathan E. Allen
Informatics Thrust Leader, Biosecurity Center at ATOM Consortium and Lawrence Livermore National Laboratory

Dr. Bill Brastow
Principal and Chief Technology Officer at Rosa Market Modeling

Stacey Tannenbaum, PhD, FISoP
Senior Director, Pharmacometrics US Clinical Pharmacology and Exploratory Development, Astellas Pharma, Northbrook, IL

Iraj Hosseini, PhD and Justin Feigelman, PhD
Scientists at Genentech, Inc in South San Francisco

Paolo Denti, PhD
Associate Professor at the University of Cape Town

Sergio Iadevaia, PhD
Scientific Director QSP, Pharmacometrics and Data Analysis at Takeda

Rajanikanth (Raj) Madabushi, PhD
Team Lead, Guidance and Policy & CDER Point-of-Contact for the MIDD paired Meeting Pilot Program, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, USFDA

Jeffrey R. Sachs, Ph.D.
Senior Principal Scientist, Merck & Co., Inc. based in Kenilworth, NJ, USA, known as MSD outside Canada and USA

Sietse Braakman, PhD
SimBiology Application Engineer at MathWorks

Dr. Britta Goebel
Head of Translational Disease Modeling (Diabetes-CV & I&I) at Sanofi, Frankfurt

Robert Bies, Pharm.D. Ph.D
Associate Professor of Pharmaceutical Sciences, Member Computational and Data Enabled Sciences Program at the University at Buffalo, NY

James Yates, MMath, PhD
Principal Scientist, AstraZeneca, Cambridge UK

Maria Trujillo PhD
Principal Scientist, Merck and Co Inc, Kenilworth, NJ

Loveleena Bansal, PhD
Scientific Leader, GSK Associate Fellow, at GSK, Collegeville PA

Vivaswath S. Ayyar, Ph.D.
Adjunct Assistant Professor of Pharmaceutical Sciences, University at Buffalo, NY and PK/PD Scientist, Janssen BioTherapeutics, Spring House, PA

Dr.-Ing. Markus Rehberg
Scientist QSP at Sanofi-Aventis Deutschland GmbH

Stephan Schmidt, B.Pharm, Ph.D., F.C.P.
Associate Professor & Associate Director, Center for Pharmacometrics & Systems Pharmacology, University of Florida

Professor Ioannis (Yannis) P. Androulakis
Rutgers University - Biomedical Engineering

Chi-Chung Li, Ph.D., Senior Scientist, Clinical Pharmacology, and Iraj Hosseini, PhD. Scientist
Genentech, Roche, South San Francisco.